100 related articles for article (PubMed ID: 17446189)
1. Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone.
Abdallah BM; Ding M; Jensen CH; Ditzel N; Flyvbjerg A; Jensen TG; Dagnaes-Hansen F; Gasser JA; Kassem M
Endocrinology; 2007 Jul; 148(7):3111-21. PubMed ID: 17446189
[TBL] [Abstract][Full Text] [Related]
2. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
[TBL] [Abstract][Full Text] [Related]
3. Expression, biosynthesis and release of preadipocyte factor-1/ delta-like protein/fetal antigen-1 in pancreatic beta-cells: possible physiological implications.
Friedrichsen BN; Carlsson C; Møldrup A; Michelsen B; Jensen CH; Teisner B; Nielsen JH
J Endocrinol; 2003 Feb; 176(2):257-66. PubMed ID: 12553874
[TBL] [Abstract][Full Text] [Related]
4. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
5. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
[TBL] [Abstract][Full Text] [Related]
6. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro.
Chacón MR; Miranda M; Jensen CH; Fernández-Real JM; Vilarrasa N; Gutiérrez C; Näf S; Gomez JM; Vendrell J
Int J Obes (Lond); 2008 Jul; 32(7):1122-9. PubMed ID: 18392037
[TBL] [Abstract][Full Text] [Related]
7. Delta-like 1/fetal antigen-1 (Dlk1/FA1) is a novel regulator of chondrogenic cell differentiation via inhibition of the Akt kinase-dependent pathway.
Chen L; Qanie D; Jafari A; Taipaleenmaki H; Jensen CH; Säämänen AM; Sanz ML; Laborda J; Abdallah BM; Kassem M
J Biol Chem; 2011 Sep; 286(37):32140-9. PubMed ID: 21724852
[TBL] [Abstract][Full Text] [Related]
8. The crosstalk between transforming growth factor-β1 and delta like-1 mediates early chondrogenesis during embryonic endochondral ossification.
Taipaleenmäki H; Harkness L; Chen L; Larsen KH; Säämänen AM; Kassem M; Abdallah BM
Stem Cells; 2012 Feb; 30(2):304-13. PubMed ID: 22102178
[TBL] [Abstract][Full Text] [Related]
9. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
11. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
[TBL] [Abstract][Full Text] [Related]
12. Isolation and differentiation of chondrocytic cells derived from human embryonic stem cells using dlk1/FA1 as a novel surface marker.
Harkness L; Taipaleenmaki H; Mahmood A; Frandsen U; Saamanen AM; Kassem M; Abdallah BM
Stem Cell Rev Rep; 2009 Dec; 5(4):353-68. PubMed ID: 20058200
[TBL] [Abstract][Full Text] [Related]
13. dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors.
Abdallah BM; Boissy P; Tan Q; Dahlgaard J; Traustadottir GA; Kupisiewicz K; Laborda J; Delaisse JM; Kassem M
J Biol Chem; 2007 Mar; 282(10):7339-51. PubMed ID: 17182623
[TBL] [Abstract][Full Text] [Related]
14. Estrogen inhibits Dlk1/FA1 production: a potential mechanism for estrogen effects on bone turnover.
Abdallah BM; Bay-Jensen AC; Srinivasan B; Tabassi NC; Garnero P; Delaissé JM; Khosla S; Kassem M
J Bone Miner Res; 2011 Oct; 26(10):2548-51. PubMed ID: 21681814
[TBL] [Abstract][Full Text] [Related]
15. Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels.
Andersen M; Jensen CH; Støving RK; Larsen JB; Schrøder HD; Teisner B; Hagen C
J Clin Endocrinol Metab; 2001 Nov; 86(11):5465-70. PubMed ID: 11701723
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.
Johansson AG; Forslund A; Hambraeus L; Blum WF; Ljunghall S
J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
[TBL] [Abstract][Full Text] [Related]
19. The effects of gonadectomy on bone size, mass, and volumetric density in growing rats are gender-, site-, and growth hormone-specific.
Zhang XZ; Kalu DN; Erbas B; Hopper JL; Seeman E
J Bone Miner Res; 1999 May; 14(5):802-9. PubMed ID: 10320529
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and tamoxifen interplay with T(3) in male rats: pharmacologically distinct classes of estrogen responses affecting growth, bone, and lipid metabolism, and their relation to serum GH and IGF-I.
Fitts JM; Klein RM; Powers CA
Endocrinology; 2001 Oct; 142(10):4223-35. PubMed ID: 11564678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
